Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C W Jenke

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Viral Hepatitis|August 18, 2009
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapyA C W Jenke, S Moser, V Orth, et al.
Gene|February 6, 2003
Chromosome-based vectors for gene therapyH J Lipps, A C W Jenke, K Nehlsen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Viral Hepatitis|August 18, 2009
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapyA C W Jenke, S Moser, V Orth, et al.
Gene|February 6, 2003
Chromosome-based vectors for gene therapyH J Lipps, A C W Jenke, K Nehlsen, et al.
Pageof 1